down arrow

Sanjiv.Parant.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE860D01013
  • NSEID:
  • BSEID: 531569
INR
235.95
7 (3.06%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 1.69 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

229.95240.00

52 Week

143.10396.95
Valuation
Technical
Day's Volume

CASH

1.69 k (-62.04%) Volume

Shareholding (Dec 2024)

FII

0.00%

Held by 0 FIIs

DII

6.25%

Held by 0 DIIs

Promoter

27.67%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Flat results in Dec 24

 
2

Stock is technically in a Bearish range

3

With ROE of 22.5, it has a Very Expensive valuation with a 8.5 Price to Book Value

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 280 Cr (Micro Cap)

stock-summary
P/E

38.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.06

stock-summary
Return on Equity

22.48%

stock-summary
Price to Book

8.53

Revenue and Profits (1 Year):
Net Sales:
17 Cr
(Quarterly Results - Dec 2024)
Net Profit:
2 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-20.86%
0%
-20.86%
1 Year
58.46%
0%
58.46%
2 Years
484.61%
0%
484.61%
3 Years
268.67%
0%
268.67%
4 Years
2045.0%
0%
2045.0%
5 Years
2753.08%
0%
2753.08%

Sanjiv.Parant. for the last several years.

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
29.34%
EBIT Growth (5y)
43.67%
EBIT to Interest (avg)
5.11
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
-1.83
Tax Ratio
25.26%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
6.25%
ROCE (avg)
-6.45%
ROE (avg)
10.85%
Valuation key factors
Factor
Value
P/E Ratio
38
Industry P/E
33
Price to Book Value
8.53
EV to EBIT
29.69
EV to EBITDA
27.65
EV to Capital Employed
8.08
EV to Sales
4.23
PEG Ratio
18.16
Dividend Yield
NA
ROCE (Latest)
25.24%
ROE (Latest)
22.48%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
Bullish
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Ashwani Khemka (25.9%)

Highest Public shareholder

Suresh Pukhraj Jain . (6.8%)

Individual Investors Holdings

54.08%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -4.30% vs 10.28% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -17.39% vs 34.50% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "17.35",
          "val2": "18.13",
          "chgp": "-4.30%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2.55",
          "val2": "2.86",
          "chgp": "-10.84%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.19",
          "val2": "0.18",
          "chgp": "5.56%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "1.90",
          "val2": "2.30",
          "chgp": "-17.39%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "14.70%",
          "val2": "15.77%",
          "chgp": "-1.07%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 30.06% vs 45.64% in Sep 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 23.01% vs 27.34% in Sep 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "34.57",
          "val2": "26.58",
          "chgp": "30.06%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "5.19",
          "val2": "4.12",
          "chgp": "25.97%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.20",
          "val2": "0.09",
          "chgp": "122.22%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "4.01",
          "val2": "3.26",
          "chgp": "23.01%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "15.01%",
          "val2": "15.50%",
          "chgp": "-0.49%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 24.99% vs 51.77% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 20.37% vs 39.89% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "51.92",
          "val2": "41.54",
          "chgp": "24.99%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "7.74",
          "val2": "6.08",
          "chgp": "27.30%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.39",
          "val2": "0.17",
          "chgp": "129.41%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "5.91",
          "val2": "4.91",
          "chgp": "20.37%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "14.91%",
          "val2": "14.64%",
          "chgp": "0.27%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 53.31% vs 15.94% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 36.81% vs -7.01% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "54.41",
          "val2": "35.49",
          "chgp": "53.31%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "8.24",
          "val2": "5.64",
          "chgp": "46.10%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.25",
          "val2": "0.36",
          "chgp": "-30.56%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "6.17",
          "val2": "4.51",
          "chgp": "36.81%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "15.14%",
          "val2": "15.89%",
          "chgp": "-0.75%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
17.35
18.13
-4.30%
Operating Profit (PBDIT) excl Other Income
2.55
2.86
-10.84%
Interest
0.19
0.18
5.56%
Exceptional Items
0.00
0.00
Standalone Net Profit
1.90
2.30
-17.39%
Operating Profit Margin (Excl OI)
14.70%
15.77%
-1.07%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is -4.30% vs 10.28% in Sep 2024

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Dec 2024 is -17.39% vs 34.50% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Standalone) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
34.57
26.58
30.06%
Operating Profit (PBDIT) excl Other Income
5.19
4.12
25.97%
Interest
0.20
0.09
122.22%
Exceptional Items
0.00
0.00
Standalone Net Profit
4.01
3.26
23.01%
Operating Profit Margin (Excl OI)
15.01%
15.50%
-0.49%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 30.06% vs 45.64% in Sep 2023

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2024 is 23.01% vs 27.34% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Standalone) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
51.92
41.54
24.99%
Operating Profit (PBDIT) excl Other Income
7.74
6.08
27.30%
Interest
0.39
0.17
129.41%
Exceptional Items
0.00
0.00
Standalone Net Profit
5.91
4.91
20.37%
Operating Profit Margin (Excl OI)
14.91%
14.64%
0.27%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 24.99% vs 51.77% in Dec 2023

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2024 is 20.37% vs 39.89% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Standalone) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
54.41
35.49
53.31%
Operating Profit (PBDIT) excl Other Income
8.24
5.64
46.10%
Interest
0.25
0.36
-30.56%
Exceptional Items
0.00
0.00
Standalone Net Profit
6.17
4.51
36.81%
Operating Profit Margin (Excl OI)
15.14%
15.89%
-0.75%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 53.31% vs 15.94% in Mar 2023

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2024 is 36.81% vs -7.01% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Sanjivani Paranteral Ltd stock-summary
stock-summary
Sanjivani Paranteral Ltd
Micro Cap
Pharmaceuticals & Drugs
Sanjivani Paranteral Ltd is a WHO-GMP certified core pharmaceutical company and a pioneer in the manufacturing of injectables and oral solids with an extensive experience spanning two-and-a-half-decades. The Company primarily focus on life-saving drugs and has exports to over 25 countries, while catering to the needs of a vast geographic area through two WHO-GMP certified manufacturing facilities in Mumbai and Dehradun. Incorporated as a public limited company in Oct.
Company Coordinates stock-summary
Company Details
205 P N Khotari Indl Estate, LBS Marg Bhandup (West) Mumbai Maharashtra : 400078
stock-summary
Tel: 91-22-67290900
stock-summary
http://www.sanjivani.co.in
stock-summary
info@sanjivani.co.in
Registrar Details
Link Intime India Pvt Ltd, C-13 Pannalal Silk Compound, L B S Marg, Bhandup , Mumbai
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."